Cargando…

The Mineralocorticoid Agonist Fludrocortisone Promotes Survival and Proliferation of Adult Hippocampal Progenitors

Glucocorticoid receptor (GR) activation has been shown to reduce adult hippocampal progenitor cell proliferation and neurogenesis. By contrast, mineralocorticoid receptor (MR) signaling is associated with neuronal survival in the dentate gyrus of the hippocampus, and impairment of hippocampal MR has...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gesmundo, Iacopo, Villanova, Tania, Gargantini, Eleonora, Arvat, Emanuela, Ghigo, Ezio, Granata, Riccarda
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2016
Materias:	Endocrinology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4910464/ https://www.ncbi.nlm.nih.gov/pubmed/27379018 http://dx.doi.org/10.3389/fendo.2016.00066

Ejemplares similares

Role of Melatonin, Galanin, and RFamide Neuropeptides QRFP26 and QRFP43 in the Neuroendocrine Control of Pancreatic β-Cell Function
por: Gesmundo, Iacopo, et al.
Publicado: (2017)

Calcitriol Inhibits Viability and Proliferation in Human Malignant Pleural Mesothelioma Cells
por: Gesmundo, Iacopo, et al.
Publicado: (2020)

Obestatin Enhances In Vitro Generation of Pancreatic Islets through Regulation of Developmental Pathways
por: Baragli, lessandra, et al.
Publicado: (2013)

Correction: Obestatin Enhances In Vitro Generation of Pancreatic Islets through Regulation of Developmental Pathways
por: Baragli, lessandra, et al.
Publicado: (2013)

The selective mineralocorticoid receptor modulator AZD9977 reveals differences in mineralocorticoid effects of aldosterone and fludrocortisone
por: Bamberg, Krister, et al.
Publicado: (2019)

Agonist of growth hormone-releasing hormone improves the disease features of spinal muscular atrophy mice
por: Boido, Marina, et al.
Publicado: (2023)

Neuroregulation of the Hypothalamus-Pituitary-Adrenal (HPA) Axis in Humans: Effects of GABA-, Mineralocorticoid-, and GH-Secretagogue-Receptor Modulation
por: Giordano, Roberta, et al.
Publicado: (2006)

Phase 1B study of the safety and tolerability of the mineralocorticoid fludrocortisone acetate in patients with geographical atrophy
por: Hong, Thomas, et al.
Publicado: (2022)

Antagonists of growth hormone-releasing hormone (GHRH) inhibit the growth of human malignant pleural mesothelioma
por: Villanova, Tania, et al.
Publicado: (2019)

Use of Plasma Renin Activity to Monitor Mineralocorticoid Treatment in Dogs with Primary Hypoadrenocorticism: Desoxycorticosterone Versus Fludrocortisone
por: Baumstark, M.E., et al.
Publicado: (2014)

Renin and electrolytes indicate the mineralocorticoid activity of fludrocortisone: a 6 year study in primary adrenal insufficiency
por: Ceccato, F., et al.
Publicado: (2022)

Unacylated Ghrelin Rescues Endothelial Progenitor Cell Function in Individuals With Type 2 Diabetes
por: Togliatto, Gabriele, et al.
Publicado: (2010)

Growth hormone-releasing hormone attenuates cardiac hypertrophy and improves heart function in pressure overload-induced heart failure
por: Gesmundo, Iacopo, et al.
Publicado: (2017)

Hypothalamic-Pituitary Autoimmunity and Traumatic Brain Injury
por: Guaraldi, Federica, et al.
Publicado: (2015)

Use of fludrocortisone for intradialytic hypotension
por: Seo, Yuri, et al.
Publicado: (2018)

Editorial: Neuroendocrine Control of Feeding Behavior
por: Luquet, Serge H., et al.
Publicado: (2019)

Growth hormone-releasing hormone antagonist MIA-602 inhibits inflammation induced by SARS-CoV-2 spike protein and bacterial lipopolysaccharide synergism in macrophages and human peripheral blood mononuclear cells
por: Granato, Giuseppina, et al.
Publicado: (2023)

Mineralocorticoid Receptors in the Pathophysiology of Vascular Inflammation and Atherosclerosis
por: Moss, Mary E., et al.
Publicado: (2015)

Role of Aldosterone and Mineralocorticoid Receptor in Cardiovascular Aging
por: Gorini, Stefania, et al.
Publicado: (2019)

Fludrocortisone Induces Aortic Pathologies in Mice
por: Ye, Dien, et al.
Publicado: (2022)

Adipose Tissue Dysfunction in Obesity: Role of Mineralocorticoid Receptor
por: Parasiliti-Caprino, Mirko, et al.
Publicado: (2022)

Antagonist of Growth Hormone-Releasing Hormone Potentiates the Antitumor Effect of Pemetrexed and Cisplatin in Pleural Mesothelioma
por: Gesmundo, Iacopo, et al.
Publicado: (2022)

Urinary Exosomes and Their Cargo: Potential Biomarkers for Mineralocorticoid Arterial Hypertension?
por: Barros, Eric R., et al.
Publicado: (2017)

Real-World Effectiveness of Mineralocorticoid Receptor Antagonists in Primary Aldosteronism
por: Tezuka, Yuta, et al.
Publicado: (2021)

Successful Use of Fludrocortisone in a Child with Refractory Cerebral Salt Wasting Syndrome: A Case Report and Review of Literature
por: Gurnurkar, Shilpa, et al.
Publicado: (2018)

The Cardiac Mineralocorticoid Receptor (MR): A Therapeutic Target Against Ventricular Arrhythmias
por: Rossier, Michel F.
Publicado: (2021)

Thermomagnetic Resonance Effect of the Extremely Low Frequency Electromagnetic Field on Three-Dimensional Cancer Models
por: Bergandi, Loredana, et al.
Publicado: (2022)

Fludrocortisone Therapy in Renal Transplant Recipients with Persistent Hyperkalemia
por: Marfo, K., et al.
Publicado: (2012)

Dexamethasone and Fludrocortisone Inhibit Hedgehog Signaling in Embryonic Cells
por: Chahal, Kirti Kandhwal, et al.
Publicado: (2018)

Fludrocortisone/hydrocortisone: Lack of efficacy: 2 case reports
Publicado: (2021)

The expression of glucocorticoid and mineralocorticoid receptors in pituitary tumors causing Cushing’s disease and silent corticotroph tumors
por: Kober, Paulina, et al.
Publicado: (2023)

Adipocyte-derived extracellular vesicles regulate survival and function of pancreatic β cells
por: Gesmundo, Iacopo, et al.
Publicado: (2021)

Use of midodrine and fludrocortisone in neurogenic shock: A case report
por: Kripa, KC, et al.
Publicado: (2021)

Traumatic Brain Injury as Frequent Cause of Hypopituitarism and Growth Hormone Deficiency: Epidemiology, Diagnosis, and Treatment
por: Gasco, Valentina, et al.
Publicado: (2021)

SAT-564 Effectiveness of Treatment with Mineralocorticoid Receptor Antagonistsin Primary Aldosteronism
por: Tezuka, Yuta, et al.
Publicado: (2020)

SAT-561 Effects of Mineralocorticoid Receptor Antagonists on Primary Aldosteronism Screening
por: Tezuka, Yuta, et al.
Publicado: (2020)

Hydrocortisone with fludrocortisone for septic shock: a systematic review and meta‐analysis
por: Yamamoto, Ryo, et al.
Publicado: (2020)

Does fludrocortisone treatment cause hypomagnesemia in children with primary adrenal insufficiency?
por: ERBAŞ, İbrahim Mert, et al.
Publicado: (2021)

ODP184 Diabetic Postural Dizziness,Hyperlactatemia,Hyponatremia-Role of Fludrocortisone
por: Singh, Santosh
Publicado: (2022)

Impact of Fludrocortisone on the Outcomes of Subarachnoid Hemorrhage Patients: A Retrospective Analysis
por: Mistry, Akshitkumar M., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_2atibga7hv8mn0j23osmqblqc4